BioXcel Therapeutics Inc (BTAI)
2.18
-0.06
(-2.90%)
USD |
NASDAQ |
Mar 26, 16:00
2.15
-0.03
(-1.38%)
After-Hours: 07:57
BioXcel Therapeutics Total Liabilities (Quarterly): 134.52M for Sept. 30, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Omeros Corp | 467.51M |
| Chimerix Inc | 24.33M |
| scPharmaceuticals Inc | 94.20M |
| IGM Biosciences Inc | 217.54M |
| ZyVersa Therapeutics Inc | 12.40M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 48.89M |
| Shareholders Equity (Quarterly) | -85.63M |
| Debt to Equity Ratio | -1.220 |
| Current Ratio | 1.87 |
| Net Debt Paydown Yield | -5.86% |